Variant report
Variant | esv3498942 |
---|---|
Chromosome Location | chr8:130435085-130443122 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:9)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:9 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:130438946..130441544-chr8:130456592..130459697,3 | K562 | blood: | |
2 | chr11:62608631..62609567-chr8:130435702..130436693,2 | NB4 | blood: | |
3 | chr8:130433486..130436461-chr8:130437244..130438809,2 | K562 | blood: | |
4 | chr8:130432582..130435209-chr8:130544896..130547721,2 | K562 | blood: | |
5 | chr8:130433486..130436461-chr8:130437244..130438809,2 | K562 | blood: | |
6 | chr8:130438496..130440259-chr8:130595633..130598498,2 | K562 | blood: | |
7 | chr8:130324110..130326533-chr8:130436449..130439248,2 | K562 | blood: | |
8 | chr8:130443086..130445932-chr8:130472163..130473857,2 | MCF-7 | breast: | |
9 | chr8:130429538..130431900-chr8:130434547..130436688,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000133316 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs560614976 | chr8:130435109-130435110 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs573065847 | chr8:130435163-130435164 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs73709741 | chr8:130435165-130435166 | Weak transcription Enhancers Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs564935219 | chr8:130435190-130435191 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs140362412 | chr8:130435219-130435220 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs79436700 | chr8:130435269-130435270 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs562491313 | chr8:130435270-130435271 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs144287728 | chr8:130435294-130435295 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs547881260 | chr8:130435328-130435329 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs566274330 | chr8:130435372-130435373 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs117772225 | chr8:130435377-130435378 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs147804825 | chr8:130435383-130435384 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs116542519 | chr8:130435469-130435470 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs538512950 | chr8:130435482-130435483 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs115924314 | chr8:130435500-130435501 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs574881842 | chr8:130435539-130435540 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs535892555 | chr8:130435564-130435565 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs1118872 | chr8:130435581-130435582 | Weak transcription Enhancers Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs572526718 | chr8:130435598-130435599 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs543963875 | chr8:130435614-130435615 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs139446031 | chr8:130435615-130435616 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs565058542 | chr8:130435635-130435636 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs576999816 | chr8:130435651-130435652 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs544478409 | chr8:130435654-130435655 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs142516584 | chr8:130435665-130435666 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs529634730 | chr8:130435709-130435710 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs372945431 | chr8:130435711-130435712 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs574200812 | chr8:130435836-130435837 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs75707853 | chr8:130435870-130435871 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs184019020 | chr8:130435896-130435897 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs185078164 | chr8:130435923-130435924 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs7816607 | chr8:130435981-130435982 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs552016009 | chr8:130435989-130435990 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs571010503 | chr8:130436008-130436009 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs189881437 | chr8:130436020-130436021 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs141011165 | chr8:130436023-130436024 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs550447435 | chr8:130436064-130436065 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs568724012 | chr8:130436073-130436074 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs536164399 | chr8:130436096-130436097 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs148306089 | chr8:130436099-130436100 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs202043240 | chr8:130436100-130436101 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs575589546 | chr8:130436121-130436122 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs554174608 | chr8:130436144-130436145 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs541400125 | chr8:130436158-130436159 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs151314604 | chr8:130436172-130436173 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs539898219 | chr8:130436198-130436199 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs182243496 | chr8:130436216-130436217 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs576957085 | chr8:130436258-130436259 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs544122030 | chr8:130436292-130436293 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs556323283 | chr8:130436325-130436326 | Weak transcription Enhancers Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Gastric cancer | 17908304 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Developmental delay | 21147756 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Papillary thyroid cancer | 17515504 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Gastric cancer | 21528007 | CNVD |
Breast cancer | 22532251 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21129771 | CNVD |
benign familial neonatal convulsions | 18472482 | CNVD |
Breast cancer | 16417655 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21183584 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Breast cancer | 20814816 | CNVD |
Colorectal cancer | 22486879 | CNVD |
Breast cancer | 17908964 | CNVD |
Colorectal cancer | 20031965 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Ovarian cancer | 17908964 | CNVD |
Ovarian cancer | 20031965 | CNVD |
Prostate cancer | 20031965 | CNVD |
Non-small cell lung cancer | 17643093 | CNVD |
Prostate cancer | 19242612 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Acute myeloid leukemia | 17268525 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Breast cancer | 22048815 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Lung adenocarcinoma | 21148746 | CNVD |
Lung cancer | 21911935 | CNVD |
Breast cancer | 20459607 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Colorectal cancer | 22860045 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Lung cancer | 17925434 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Prostate cancer | 17217626 | CNVD |
Cancer | 17160897 | CNVD |
Breast cancer | 16497871 | CNVD |
Colorectal cancer | 16882699 | CNVD |
Cystic fibrosis | 19273617 | CNVD |
Chronic stroke | 19622162 | CNVD |
Chordoma | 18071362 | CNVD |
Breast cancer | 17850661 | CNVD |
head and neck squamous cell carcinoma | 16740747 | CNVD |
Gastric cancer | 22539939 | CNVD |
Breast cancer | 16272173 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Breast cancer | 16620391 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21611746 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:130427000-130449000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr8:130429400-130437600 | Enhancers | Dnd41 | blood |
3 | chr8:130430200-130435600 | Enhancers | Primary monocytes fromperipheralblood | blood |
4 | chr8:130431200-130436000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
5 | chr8:130431600-130435800 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
6 | chr8:130432800-130436600 | Enhancers | Fetal Thymus | thymus |
7 | chr8:130433000-130435200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
8 | chr8:130433000-130435400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
9 | chr8:130433200-130436600 | Genic enhancers | K562 | blood |
10 | chr8:130434200-130435600 | Enhancers | Monocytes-CD14+_RO01746 | blood |
11 | chr8:130434200-130436400 | Enhancers | Thymus | Thymus |
12 | chr8:130434600-130435200 | Enhancers | Right Atrium | heart |
13 | chr8:130434600-130435200 | Enhancers | Spleen | Spleen |
14 | chr8:130434800-130435400 | Weak transcription | Fetal Muscle Trunk | muscle |
15 | chr8:130434800-130443800 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
16 | chr8:130435000-130435400 | Enhancers | Adipose Nuclei | Adipose |
17 | chr8:130435200-130435600 | Weak transcription | Spleen | Spleen |
18 | chr8:130435200-130436600 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
19 | chr8:130435200-130436600 | Weak transcription | Right Atrium | heart |
20 | chr8:130435400-130436200 | Enhancers | Fetal Muscle Trunk | muscle |
21 | chr8:130435600-130436000 | Enhancers | Spleen | Spleen |
22 | chr8:130436000-130436400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
23 | chr8:130436400-130443800 | Weak transcription | Thymus | Thymus |
24 | chr8:130436600-130443800 | Weak transcription | K562 | blood |
25 | chr8:130437600-130439400 | Weak transcription | Dnd41 | blood |
26 | chr8:130439400-130440000 | Enhancers | Dnd41 | blood |
27 | chr8:130440000-130443400 | Weak transcription | Dnd41 | blood |